TMB-365

· TaiMed Biologics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TMB-365, covering 2025-10-22 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study [Phase 2]